Search results

Order by most recent / most popular / relevance

Results: 1-10 of 1,409

Universities abroad experiment with no-fee licensing to drive biotech partnerships

Shook Hardy & Bacon LLP
-
Australia, Canada, European Union, United Kingdom, USA
-
May 16 2013

Universities in Australia, Canada, Europe, and the United Kingdom have reportedly embraced a 2010 Glasgow University initiative under which companies

Supreme Court declines to hear Eli Lilly’s “promise of the patent” appeal

Bereskin & Parr LLP
-
Canada
-
May 16 2013

The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal ("FCA") decision in Eli Lilly Canada Inc v Novopharm Ltd

What goes upmust come down: Viagra patent invalidated by Canadian Supreme Court

Drinker Biddle & Reath LLP
-
Canada
-
May 13 2013

Pfizer and Teva have been fighting a legal battle over Pfizer's patent for Viagra in Canada. The first shot was fired when Novopharm Limited, now

Ambulance service failed in duty to accommodate - manager also personally liable

McCarthy Tétrault LLP
-
Canada
-
May 10 2013

The BC Ambulance Service failed in its duty to accommodate a paramedic who could no longer palpate a pulse because of his mulitple sclerosis. The

Supreme Court of Canada denies leave to appeal in PM(NOC) judicial comity case

Bereskin & Parr LLP
-
Canada
-
May 9 2013

The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal ("FCA") decision in Allergan Inc. et al ats. Apotex Inc

Legal causation and the duty to warn

McCarthy Tétrault LLP
-
Australia, Canada
-
May 8 2013

Can a defendant be liable for failing to warn about a risk which does not materialize, where this leads the plaintiff to be injured by a second

Healthcare & life sciences private equity deal tracker: Argon Medical Devices completes acquisition of Angiotech Pharmaceuticals subsidiary

McGuireWoods LLP
-
Canada, USA
-
May 8 2013

Argon Medical Devices has completed its acquisition of the interventional products business of Angiotech Pharmaceuticals Inc., according to a news

Teva Canada Innovation v. Attorney General of Canada

Borden Ladner Gervais LLP
-
Canada
-
May 8 2013

The Patented Medicine Prices Review Board (the PMPRB) ordered Teva to pay the Crown approximately $2.4 million for selling its product at an

Federal Court sets aside PMPRB decision regarding COPAXONE syringes for the second time

Smart & Biggar/Fetherstonhaugh
-
Canada
-
May 7 2013

On April 30, 2013, Justice Zinn of the Federal Court set aside a decision of the PMPRB (the "Board"), which ordered (Order, Reasons) Teva to pay the

USTR slams Canada over the treatment of pharmaceutical patents

Norton Rose Canada LLP
-
Canada
-
May 6 2013

On May 1, 2013, the United States Trade Representative (“USTR”) released its annual IP report for 2013. Canada has been placed on the “Watch List"

next >

Search results

Universities abroad experiment with no-fee licensing to drive biotech partnerships

Supreme Court declines to hear Eli Lilly’s “promise of the patent” appeal

What goes upmust come down: Viagra patent invalidated by Canadian Supreme Court

Ambulance service failed in duty to accommodate - manager also personally liable

Supreme Court of Canada denies leave to appeal in PM(NOC) judicial comity case

Legal causation and the duty to warn

Healthcare & life sciences private equity deal tracker: Argon Medical Devices completes acquisition of Angiotech Pharmaceuticals subsidiary

Teva Canada Innovation v. Attorney General of Canada

Federal Court sets aside PMPRB decision regarding COPAXONE syringes for the second time

USTR slams Canada over the treatment of pharmaceutical patents

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea